XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 6,871,306 $ 5,345,967
Short-term investments 1,994,662 0
Accounts receivable, net 2,382,658 1,896,163
Inventories, net 1,803,507 1,399,865
Prepaid expenses and other current assets 598,850 573,462
Total Current Assets 13,650,983 9,215,457
Equipment, net 175,794 194,283
Operating lease assets with right-of-use 663,554 508,743
Investment in Jiangxi Myomo Medical Assistive Appliance Co. Ltd. 0 132,489
Other Assets 91,237 111,034
Total Assets 14,581,568 10,162,006
Current Liabilities:    
Accounts payable and accrued expenses 4,885,944 3,179,362
Current operating lease liabilities 486,143 353,701
Income taxes payable 96,461 48,220
Deferred revenue 8,510 20,653
Total Current Liabilities 5,477,058 3,601,936
Non-current operating lease liability 115,160 200,207
Deferred revenue 0 498
Total Liabilities 5,592,218 3,802,641
Commitments and Contingencies - Note 10 0 0
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding 0 0
Common stock par value $0.0001 per share 65,000,000 shares authorized; 27,135,061 and 7,750,635 shares issued as of December 31, 2023 and 2022, respectively, and 27,135,034 and 7,750,608 shares outstanding as of December 31, 2023 and 2022, respectively. 2,715 775
Additional paid-in capital 105,840,239 95,105,071
Accumulated other comprehensive income 83,669 43,227
Accumulated deficit (96,930,809) (88,783,244)
Treasury stock, at cost; 27 shares of common stock (6,464) (6,464)
Total Stockholders’ Equity 8,989,350 6,359,365
Total Liabilities and Stockholders’ Equity $ 14,581,568 $ 10,162,006